Overall survival after treatment with first-line osimertinib for EGFR-mutant advanced NSCLC in the US Meeting Abstract
| Authors: | Sabari, J. K.; Yu, H. A.; Mahadevia, P.; Liu, Y.; Demirdjian, L.; Sultan, A. A.; Chen, Y. H.; Wang, X.; Passaro, A. |
| Abstract Title: | Overall survival after treatment with first-line osimertinib for EGFR-mutant advanced NSCLC in the US |
| Meeting Title: | 2024 World Conference on Lung Cancer |
| Keywords: | overall survival; osimertinib; real-world observational cohort study |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2024 Sep 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S619 |
| End Page: | S620 |
| Language: | English |
| ACCESSION: | WOS:001337925604084 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.09.1162 |
| Notes: | Meeting Abstract: EP.12A.03 -- Source: Wos |
